טיפול משולב המכיל תרכובת דיהידופיראזינו–פיראזין ואנטגוניסט לקולטן אנדרוגני לטיפול בסרטן הערמונית
- 专利权人:
- SIGNAL PHARMACEUTICALS LLC
- 发明人:
- 申请号：
- IL24202215
- 公开号：
- IL242022A
- 申请日:
- 2015.10.12
- 申请国别(地区):
- IL
- 年份:
- 2020
- 代理人:
- 摘要：
- Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound and an effective amount of an androgen receptor antagonist to a patient having a cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- КОМБІНОВАНА ТЕРАПІЯ, ЯКА ВКЛЮЧАЄ СПОЛУКУ ДИГІДРОПІРАЗИНОПІРАЗИНУ Й АНТАГОНІСТ РЕЦЕПТОРА АНДРОГЕНУ, ДЛЯ ЛІКУВАННЯ РАКУ ПРОСТАТИ
- COMBINATION THERAPY COMPRISING A DIHYDROPYRAZINO-PYRAZINE COMPOUND AND AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATING PROSTATE CANCER
- COMBINATION THERAPY COMPRISING A DIHYDROPYRAZINO-PYRAZINE COMPOUND AND AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATING PROSTATE CANCER
- COMBINATION THERAPY COMPRISING A DIHYDROPYRAZINO-PYRAZINE COMPOUND AND AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATING PROSTATE CANCER
- COMBINATION THERAPY COMPRISING A DIHYDROPYRAZINO-PYRAZINE COMPOUND AND AN ANDROGEN RECEPTOR ANTAGONIST FOR TREATING PROSTATE CANCER
